Latest Galaxy Medicare stock price
Galaxy Medicare P/E Ratio
GML • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
9.5
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
9.5
Current Price
₹
EPS (TTM)
₹2.84
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
53.73
Sector Median
31.12
Sector Rank
#6 of 131
Sector Percentile
4.6%
Key P/E Ratio Insights for Galaxy Medicare
- Stock appears undervalued with PE of 9.5, suggesting potential buying opportunity
- Trading at discount to sector average PE of 53.73
View the GML equity price for detailed stock performance.
Related Pages for Galaxy Medicare
Additional stock information and data for GML
Sector P/E Ratio Comparison
Comparing Galaxy Medicare with other companies in Healthcare sector
Sector Average
53.73
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |